Latest in AI
What AI is actually doing in your industry.
Real deployments, real numbers — reviewed by our team. No hype.
Valo Health Taps Dr. Chris Anagnostopoulos as Chief Causal AI Officer - contractpharma.com
Valo Health, a drug discovery company, has appointed Dr. Chris Anagnostopoulos as Chief Causal AI Officer. This signals continued investment in AI leadership within the pharmaceutical sector. For pharma firms, it reflects a growing trend of creating senior roles dedicated to applying AI to research and development.
Lilly names Mount Sinai scientist as first chief AI officer - BioPharma Dive
Eli Lilly has appointed its first chief AI officer, a scientist recruited from Mount Sinai, signalling a formal push to embed AI across its drug development and operations. For pharma companies, this reflects a broader trend of large drugmakers creating dedicated senior roles to lead AI strategy. It suggests AI is becoming a board-level priority in the sector rather than a side project.